Suppr超能文献

伴有快速进展性肾小球肾炎和鞍鼻畸形的MPO-ANCA阳性肉芽肿性多血管炎:一例报告

MPO-ANCA-Positive Granulomatosis with Polyangiitis with Rapidly Progressive Glomerulonephritis and Saddle-Nose Deformity: A Case Report.

作者信息

Petrou Dimitra, Karagiannis Minas, Nikolopoulos Petros, Liapis George, Lionaki Sophia

机构信息

Department of Nephrology, National and Kapodistrian University of Athens, Attikon Hospital, 12462 Athens, Greece.

Department of Pathology, National and Kapodistrian University of Athens, Laiko Hospital, 11527 Athens, Greece.

出版信息

Antibodies (Basel). 2022 May 9;11(2):33. doi: 10.3390/antib11020033.

Abstract

Early diagnosis and initiation of appropriate immunosuppressive treatment remain the cornerstone of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis at the cost of significant toxicity. In this report, we present a case of a 69-year-old female who presented with advanced renal insufficiency and evidence of pulmonary hemorrhage and was MPO-ANCA-positive with a clinical phenotype of granulomatosis with polyangiitis. Organ involvement included rapidly progressive glomerulonephritis (GN), along with extrarenal manifestations (skin, upper and lower respiratory system involvement, and onset of saddle-nose deformity). Kidney biopsy established the diagnosis of pauci-immune crescentic, sclerotic GN. She received therapy with glucocorticoids and cyclophosphamide, mainly due to life-threatening extra-renal manifestations, such as pulmonary hemorrhage. She avoided vasculitis-related death but she developed severe therapy-related toxicity, resulting in the discontinuation of immunosuppressive therapy. Continuous re-evaluation of patients with ANCA-associated vasculitis in terms of response to immunosuppressive therapy and treatment-related toxicity is crucial for their management.

摘要

早期诊断并开始适当的免疫抑制治疗仍然是以显著毒性为代价的抗中性粒细胞胞浆抗体(ANCA)相关血管炎的基石。在本报告中,我们介绍了一名69岁女性病例,该患者出现晚期肾功能不全及肺出血证据,髓过氧化物酶抗中性粒细胞胞浆抗体(MPO-ANCA)阳性,具有肉芽肿性多血管炎的临床表型。器官受累包括快速进展性肾小球肾炎(GN)以及肾外表现(皮肤、上下呼吸道系统受累,出现鞍鼻畸形)。肾脏活检确诊为寡免疫性新月体性、硬化性GN。她接受了糖皮质激素和环磷酰胺治疗,主要是因为存在威胁生命的肾外表现,如肺出血。她避免了血管炎相关死亡,但出现了严重的治疗相关毒性,导致免疫抑制治疗中断。对ANCA相关血管炎患者在免疫抑制治疗反应和治疗相关毒性方面进行持续重新评估对其管理至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee80/9149920/7433af5c9f6f/antibodies-11-00033-g001.jpg

相似文献

引用本文的文献

本文引用的文献

3
ANCA-associated vasculitis.抗中性粒细胞胞浆抗体相关性血管炎。
Nat Rev Dis Primers. 2020 Aug 27;6(1):71. doi: 10.1038/s41572-020-0204-y.
4
ANCA-Associated Vasculitis: Core Curriculum 2020.抗中性粒细胞胞质抗体相关性血管炎:2020 年核心课程。
Am J Kidney Dis. 2020 Jan;75(1):124-137. doi: 10.1053/j.ajkd.2019.04.031. Epub 2019 Jul 26.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验